Bayer's Mirena IUD gets expanded indication
This article was originally published in The Gray Sheet
Executive Summary
Bayer Healthcare's Mirena intrauterine device gains expanded FDA approval Oct. 1 to treat heavy menstrual bleeding in women who use intrauterine contraception for pregnancy prevention, making it the first IUD approved for the additional indication. Mirena, a small flexible hormone-releasing device inserted in the uterus, was approved as a contraceptive in 2000